Portevo
WSE companies
RVUWarsaw Stock Exchange

Ryvu Therapeutics (RVU) Financial Results

Report publication dates, analyst consensus, and how Ryvu Therapeutics' share price reacted to previous earnings — all in one place, in English.

Updated: October 11, 2026

Share Price
16.50 PLN
+1.35%
Market Cap
381.48M PLN

When Ryvu Therapeutics Releases Earnings

The date of Ryvu Therapeutics' next earnings release is not yet known. Companies usually announce it a few weeks before the report — the in-app calendar updates automatically when the date becomes available.

Insider Transactions: Ryvu Therapeutics

Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.

Insider Buys · 12 mo.
0
—
Sales · 12 mo.
1
Unique individuals
1
in the last year
Last transaction
April 13, 2026
Latest transactionsForm 4, STOCK Act, OGE, MAR
Vatnak Vat-Ho · sale RVU.WA
304k PLN13 April 2026
Tadeusz Wesołowski · purchase RVU.WA
Ryvu Therapeutics S.A. · by related entity
PLN 241k, June 13, 2025
Tadeusz Wesołowski · sale RVU.WA
Ryvu Therapeutics S.A. · by related entity
PLN 241k, June 13, 2025
Tadeusz Wesołowski · sale RVU.WA
Ryvu Therapeutics S.A. · by related entity
PLN 21.8 million9 June 2025
Tadeusz Wesołowski · purchase RVU.WA
Ryvu Therapeutics S.A. · by related entity
PLN 21.8 million9 June 2025
Tadeusz Wesołowski · sale RVU.WA
Ryvu Therapeutics S.A. · by related entity
PLN 16.8 million4 June 2025
Tadeusz Wesołowski · purchase RVU.WA
Ryvu Therapeutics S.A. · by related entity
PLN 16.8 million4 June 2025
See insider faces on the chart in the app →

Analyst forecasts for upcoming periods

The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.

Ryvu Therapeutics forecasts — EPS in PLN.
PeriodEPS estimateEPS a year agoChangeRevenue forecastAnalysts
Current year-1.88-4.40+57.27%92.00M PLN2
Next year2.44-1.88+229.79%133.63M PLN2

Revenue and margins quarter by quarter

Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.

Ryvu Therapeutics Revenue and MarginRyvu Therapeutics quarterly revenue bar chart for the last 5 quarters; revenue is declining, with net margin overlaid.Q2 25Q3 25Q4 25Q1 26Q2 26-271.37%-165.62%-97.72%-74.61%-108.92%Quarterly revenueNet margin
Ryvu Therapeutics quarterly revenue in PLN and net margin for the same quarter.
Ryvu Therapeutics income statement, quarterly.
QuarterRevenueGross marginOperating marginNet margin
June 30, 202611.99M PLN70.61%-139.58%-108.92%
March 31, 202616.95M PLN75.63%-73.19%-74.61%
December 31, 202518.00M PLN77.34%-93.31%-97.72%
September 30, 202514.92M PLN75.61%-170.41%-165.62%
June 30, 202512.40M PLN72.77%-219.58%-271.37%

Who Reports in the Coming Weeks

Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.

About Ryvu Therapeutics

Ryvu Therapeutics S.A. is listed on the Warsaw Stock Exchange under the ticker RVU and is headquartered in Poland. The company belongs to the healthcare sector (industry: Biotechnology).

  • Ticker: RVU (trading symbol: RVU.WA)
  • Exchange: Warsaw Stock Exchange
  • Trading currency: PLN
  • Sector: healthcare
  • Number of Analysts Providing Estimates: 5
  • 52-Week Range: 0.00 – 31.90
  • Company website: https://ryvu.com

Frequently Asked Questions

When does Ryvu Therapeutics release earnings?

The date of the next release has not yet been announced. The Portevo earnings calendar updates automatically when the company provides the date.

What is Ryvu Therapeutics' ticker symbol?

RVU — on the Warsaw Stock Exchange. You may also see RVU.WA on quote services.

Where can I find Ryvu Therapeutics' financial results in English?

On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.

Other companies in the healthcare sector

A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.

Related

Track Ryvu Therapeutics on Portevo

The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.

Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.

Portevo App

Your entire portfolio, company earnings, and insider trades in one place

Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.

  • Portfolio with Net Profit After Costs
  • Earnings Calendar for Your Companies
  • Pelosi, Trump, and CEO Trades on a Chart
  • Works in Browser and on iPhone

No credit card required. A demo portfolio is available immediately; create your own by uploading a report.

Portevo Portfolio: Value, Net Performance, and ChartCompany Earnings Calendar in the Portevo AppETF Fact Sheet with Quotes in PortevoTransaction History and Portfolio Tracking in Portevo
Portevo — free portfolio, earnings, and insider tradesOpen App